Welcome to Friends’ second Quarterly Advocacy Newsletter of 2024. In Q2, Friends co-hosted a public meeting about cell therapies with the Parker Institute for Cancer Immunotherapy, published several peer-reviewed manuscripts, and launched a webpage for patients and advocates, including a section about our Advisory Advocates. We’re so excited to share these and other happenings at…
Welcome to Friends’ first Quarterly Patient Advocate Newsletter of 2024. 2023 Advocacy Newsletters Newsletter Feedback Form Here’s what you can read more about in this newsletter: What’s Happening at Friends?: Read about Friends’ research to ensure diagnostic tests consistently provide reliable results for patients and providers. Mark Your Calendars: Upcoming events, including public meetings hosted…
Dear Advocates, We are excited to welcome you to the fourth edition of the Friends Advocacy Newsletter. It has been a great year working with you to create and launch this resource and we want to hear your thoughts on what you have liked, what could be improved, and what you want to see more of. We…
Dear Advocates, Welcome to the third edition of the Friends of Cancer Research (Friends) Quarterly Advocacy Newsletter. We’re excited to share more about what we’ve been working on at Friends and let you know about upcoming public events and research milestones. Here’s what you can read more about in this newsletter: What’s Happening at Friends?:…
Dear Advocates, Welcome to the second edition of the Friends of Cancer Research (Friends) Quarterly Advocacy Newsletter. Here’s what you can read more about in this newsletter: What’s Happening at Friends in 2023? Friends recently presented new results from several of our initiatives at the American Society of Clinical Oncology (ASCO) Annual Meeting. Here we…
Welcome to the first edition of the Friends of Cancer Research (Friends) Quarterly Advocacy Newsletter. Friends is launching this newsletter in collaboration with our Advisory Advocates to provide a resource for staying up to date on Friends’ projects, learning about upcoming events and conferences, and understanding emerging science and policy impacting the landscape of cancer…
